Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.

Abstract

No abstract available.

Authors
  • Arredouani MS
  • Dunn LK
  • Kissick HT
  • Sanda MG
PubMed ID
24690990
Appears In